Company / Current Liabilities
Opus Genetics, Inc. Current Liabilities History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$7.8M
FY2025
5-year range
$2.8M / $11.3M
FY2021-FY2025
Trend
-31.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $4M to $8M over the past 2 years.
Based on SEC 10-K filings.
$8M in FY2025 with a 3-year CAGR of +41.4%.
Increased from $4M to $8M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +41.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +41.4%, indicating consistent growth.
- In FY2025, current liabilities decreased 31.1% year-over-year.
- Peak current liabilities was recorded in FY2024.
- Lowest current liabilities in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.8M | -31.1% |
| FY2024 | $11.3M | +179.4% |
| FY2023 | $4.0M | +46.8% |
| FY2022 | $2.8M | -28.6% |
| FY2021 | $3.9M | - |
| FY2013 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026